SARAH FAST: Open Payments
NPI 1306868781 · OZARK, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 101 payments from 20 companies in 2025. Trend: 2023 $1,153 · 2024 $2,177 · 2025 $2,247
Food & beverage: $2,247
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $505 |
| Novo Nordisk Inc | 13 | $459 |
| AstraZeneca Pharmaceuticals LP | 16 | $305 |
| ABBVIE INC. | 16 | $198 |
| PFIZER INC. | 13 | $176 |
| Alexion Pharmaceuticals, Inc. | 1 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Abbott Laboratories | 3 | $70 |
| Dexcom, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $44 |
Products named: Auvelity, Ozempic, BREZTRI, Wegovy, NURTEC ODT, FARXIGA, UBRELVY, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
